Pharmaceutical company files information from study involving over 2,000 children; says not yet requesting emergency use authorization, but expected to do so in weeks

Albert Bourla says a return to normal life could come within a year, but predicts that will include annual vaccinations

Pharmaceutical giant's CEO says finding from trial suggest booster shot elicits antibody levels significantly higher than those seen in patients who only receive two doses

Bourla says key reason Israel chosen for rollout was that then-PM 'was on top of everything'; says Holocaust survivor parents taught him he can do anything, but be ready for worst

PM's office says Albert Bourla committed to working ‘to the best of his ability’ to move the process along and expand eligibility

Nachman Ash says ministry has direct relationship with pharma companies, and booster decision should be left to experts; serious cases rise as cabinet set to meet on restrictions

Ex-PM confirms phone calls, claims 3rd vaccine shot ‘is the only way to protect the population’ despite FDA saying it’s not yet needed

PM Bennett said to have had personal talks with Pfizer CEO Albert Bourla to secure deal, though no decision has yet been made on widespread booster doses

Agreement brokered with South Korea will see Israel receive vaccines in September-November in exchange for doses set to expire at end of this month

Under agreement with Seoul, Israel to send doses that will expire by end of month and receive a similar number in return at end of year from existing South Korean deal with Pfizer